13-07-2021 16:00 via medpagetoday.com

Chemo-IO Over IO Alone in Patients With Advanced NSCLC

(MedPage Today) -- An analysis presented at the recent virtual American Society of Clinical Oncology annual meeting explored data from eight clinical trials and showed that immunotherapy plus chemotherapy (Chemo-IO) improved survival over immunotherapy...
Read more »